Kian Sadeghi

Augustus Doricko, CEO of Rainmaker, shares insights on China's weather modification program and its effects on U.S. water management. Brad Porter discusses collaborative robotics, emphasizing how AI could revolutionize logistics. Kian Sadeghi introduces Nucleus Embryo, a groundbreaking platform enabling parents to select embryos based on desired traits. Kathleen McMahon highlights the implications of bioterrorism and biodefense strategies in modern biotech. Chungin "Roy" Lee focuses on Cluely's marketing strategies and the importance of user engagement in AI tools.

Kian Sadeghi, founder and CEO of Nucleus and a Thiel Fellow, dives into the evolving world of consumer DNA testing. He discusses how Nucleus offers comprehensive genetic insights, unlike traditional tests. Sadeghi explains the innovative embryo selection process for IVF, which is gaining popularity. He also addresses the ethical implications of gene editing and the need for consumer empowerment in genetics. His bold claims and perspective on the industry spark intriguing debates, making for a thought-provoking conversation.

Kian Sadeghi, CEO of Nucleus and a pioneer in genetic optimization software, joins the discussion on revolutionary advancements in reproductive technology. He unveils Nucleus Embryo, a tool that helps parents evaluate genetic traits in embryos, enhancing health and intelligence from conception. The conversation also covers ethical implications, accessibility of such technologies, and the urgent need for informed parenting in the context of a rising fertility crisis. Kian emphasizes making these innovations universally available to empower all prospective parents.

Kian Sadeghi, founder of Nucleus, shares his journey from dropping out of UPenn to building a genetic testing company. He discusses the importance of relentlessness, talent identification, personal tragedy inspiring genomics, and embracing fear and self-belief in entrepreneurship.

Kian Sadeghi, CEO of Nucleus Genomics, discusses disrupting DNA sequencing, empowering individuals with genetic info for health decisions, advancements in DNA tech, ethics in genetic engineering, and the demanding nature of entrepreneurship.